IN FOCUS FEATURE
Biotech Leaders Look to the Future
FROM OUR WEB SITE
From Our Web Site
Phase Bio Secures $1M Equipment Loan
Durham-based Phase Bioscience will relocate its headquarters and lab facilities to Morrisville.
Biolex Results Published in Research Journal
Biolex Therapeutics Inc. has published results of the Phase 1 clinical trial of Locteron in the Journal of Interferon & Cytokine Research. The drug is a controlled-release interferon alfa being developed to treat chronic hepatitis C.
CED Selects Venture Conference Presenters
Ten North Carolina biotechnology companies will present at CED 25th Annual Venture Conference
Argolyn Moves Headquarters to RTP
Argolyn Bioscience Inc. moves its headquarters from Charleston, S.C., and expands its management team.
Inclinix Patents Interview Software System
Inclinix Inc. has received a patent for its software system used to qualify patients in clinical trials of new drugs or medical devices.
Affinergy Collects Five New SBIR Grants Worth $3M Total
Affinergy is a Duke University spinout developing a site-specific biological delivery system.
Metabolon Launches New Platform for Biochemical Profiling
Metabolon Inc. launches its third generation metabolomics platform. The enhanced platform significantly increases the speed and resolution of comprehensive biochemical profiling.
TransTech Pharma Acquires Programs for Treating Metabolic Disorders
TransTech Pharma, Inc. has acquired all rights from Novo Nordisk to three programs being developed to treat metabolic disorders. With the addition of these programs, TransTech will now be engaged in 11 clinical and preclinical programs in the diabetes and obesity area.
In Focus
Biotech Leaders Look to the Future
Arthur O. Murray, Business North Carolina's managing editor for special projects, moderated a discussion of five biotechnology leaders. The roundtable is featured in the magazine's March issue, and the podcast is now available on the Biotechnology Center's Web site.
The discussion included:
- Vipin Garg, President and Chief Executive Officer of Tranzyme Pharma
- Chris Kroeger, Partner at Aurora Funds
- Samuel Taylor, President of the North Carolina Biosciences Organization
- Norris Tolson, President and Chief Executive Officer of the North Carolina Biotechnology Center
- Sarah Yocum, Chief Executive Officer of Aqualutions Inc.
News from Other Sites
Trimeris Co-Founder Launches New Venture with Hamner
Former Trimeris leaders Dani Bolognesi and Robert Bonczek have teamed up to form b3bio, working on RNA Therapeutics. The company will be located at the Hamner Institutes for Health Sciences' Hamner Accelerator for Translational Bioscience.
From WRAL LocalTechWire
Tech-Minded: Winston-Salem is 'Walking the Walk,' Co-Founder of Community Forum Says
The leader of the group that named Winston-Salem an intelligent community was in town to talk to local leaders.
From the Winston-Salem Journal
Hoke: Ethanol Plant Gets Land
Clean Burn Fuels received approval for transfer of 500 acres of land from Hoke County.
From the Fayetteville Observer
Researchers Brace for NIH Cutbacks
North Carolina university leaders joined others in Washington to warn that less NIH funding would create problems down the road.
From the Raleigh News and Observer
Murdock funds three faculty spots at N.C. Research Campus
Faculty research positions get a $3 million boost.
From the Salisbury Post
Community Watch
- RTI International scientist Frank DeStefano, M.D., MPH, was among the experts who met Feb. 21 in Gaithersburg, Md., to select strains for 2008-2009 U.S. influenza vaccine. More.
- Philip C. Cooley, principal scientist and assistant director of bioinformatics, has been appointed an RTI International Fellow. More.
- John E. Burris, Ph.D., will become president of the Burroughs Wellcome Fund effective July 1, 2008, as announced by the board of directors. Burris is currently president of Beloit College in Wisconsin. More.
- Durham-based Quintiles Transnational Corp. announced it has achieved another major milestone in the management of clinical trial data -- 300 clinical trials using Electronic Data Capture (EDC). More.
- William R. Ringo, Jr. will resign from the board of directors of Durham-based Inspire Pharmaceuticals to become senior vice president of Strategy and Business Development at Pfizer Inc. More.
- Durham-based Cato Research Ltd., a global contract research and development organization, today announced that it has named former etrials Worldwide president and CEO John Cline as its new president. More.
- Rob Lindberg, director of the Business Acceleration and Technology Out-licensing Network(BATON) at the North Carolina Biotechnology Center, and Janice Whitaker, senior vice president of quality at GlaxoSmithKline, have joined the Industry Advisory Board of the BioPharma Management Initiative at North Carolina State University College of Management.
- Liquidia Technologies has named Neal F. Fowler as Chief Executive Officer and appointed Seth A. Rudnick, M.D., as Chairman of its Board of Directors. More.
- About 270 students from schools across North Carolina will be gathering at Meredith College on Saturday to participate in the State Science and Engineering Fair of NC. Students from 3rd through 12th grades will be presenting their original science and engineering research. More.
- Marine biotechnology is the focus of a Web site and newsletter launched by Strategro International. More.
Please send Community Watch items to Jim Shamp.
Save the Date
Apr. 16-18
Venture 08
(Durham)
May 19-20
Biotech 2008
(Winston-Salem)
June 17-20
BIO 2008 Conference
NC Pavilion Sponsorship
(San Diego)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, Mar. 13, 2008. For the latest North Carolina biotechnology industry headlines, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.